US Bancorp’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
5,532
+110
+2% +$5.65K ﹤0.01% 1960
2026
Q1
$321K Buy
5,422
+1,104
+26% +$71.6K ﹤0.01% 1742
2025
Q4
$266K Sell
4,318
-483
-10% -$29.6K ﹤0.01% 1879
2025
Q3
$300K Buy
4,801
+393
+9% +$27.4K ﹤0.01% 1796
2025
Q2
$352K Buy
4,408
+1,138
+35% +$95.2K ﹤0.01% 1697
2025
Q1
$281K Sell
3,270
-610
-16% -$50K ﹤0.01% 1825
2024
Q4
$303K Sell
3,880
-98
-2% -$7.61K ﹤0.01% 1785
2024
Q3
$287K Buy
3,978
+672
+20% +$47.6K ﹤0.01% 1835
2024
Q2
$228K Buy
3,306
+179
+6% +$12.1K ﹤0.01% 1930
2024
Q1
$227K Sell
3,127
-19
-0.6% -$1.27K ﹤0.01% 1941
2023
Q4
$193K Buy
3,146
+912
+41% +$54.2K ﹤0.01% 2024
2023
Q3
$128K Sell
2,234
-573
-20% -$34.6K ﹤0.01% 2027
2023
Q2
$167K Sell
2,807
-336
-11% -$20.1K ﹤0.01% 1962
2023
Q1
$197K Sell
3,143
-354
-10% -$22.1K ﹤0.01% 1866
2022
Q4
$219K Sell
3,497
-183
-5% -$10.5K ﹤0.01% 1810
2022
Q3
$184K Sell
3,680
-5,357
-59% -$297K ﹤0.01% 1887
2022
Q2
$531K Sell
9,037
-1,200
-12% -$66.2K ﹤0.01% 1410
2022
Q1
$541K Buy
10,237
+4,132
+68% +$239K ﹤0.01% 1493
2021
Q4
$370K Sell
6,105
-156
-2% -$9.26K ﹤0.01% 1681
2021
Q3
$351K Sell
6,261
-1,462
-19% -$80.3K ﹤0.01% 1693
2021
Q2
$402K Sell
7,723
-3,387
-30% -$163K ﹤0.01% 1659
2021
Q1
$490K Sell
11,110
-85
-0.8% -$3.57K ﹤0.01% 1511
2020
Q4
$391K Sell
11,195
-1,261
-10% -$44.8K ﹤0.01% 1572
2020
Q3
$454K Sell
12,456
-643
-5% -$23.9K ﹤0.01% 1377
2020
Q2
$492K Buy
13,099
+333
+3% +$13.3K ﹤0.01% 1302
2020
Q1
$468K Buy
12,766
+4,031
+46% +$157K ﹤0.01% 1238
2019
Q4
$354K Buy
8,735
+1,795
+26% +$67K ﹤0.01% 1542
2019
Q3
$241K Sell
6,940
-1,432
-17% -$47.2K ﹤0.01% 1718
2019
Q2
$265K Buy
8,372
+1,954
+30% +$58.1K ﹤0.01% 1697
2019
Q1
$192K Sell
6,418
-386
-6% -$11.1K ﹤0.01% 1835
2018
Q4
$210K Sell
6,804
-3,447
-34% -$126K ﹤0.01% 1742
2018
Q3
$388K Sell
10,251
-384
-4% -$14.5K ﹤0.01% 1546
2018
Q2
$409K Buy
10,635
+2,181
+26% +$73.5K ﹤0.01% 1529
2018
Q1
$285K Buy
8,454
+6,296
+292% +$242K ﹤0.01% 1689
2017
Q4
$96K Buy
2,158
+398
+23% +$18.1K ﹤0.01% 2283
2017
Q3
$88K Buy
1,760
+93
+6% +$4.75K ﹤0.01% 2306
2017
Q2
$88K Hold
1,667
﹤0.01% 2261
2017
Q1
$93K Buy
1,667
+421
+34% +$23.2K ﹤0.01% 2189
2016
Q4
$65K Sell
1,246
-71
-5% -$3.43K ﹤0.01% 2316
2016
Q3
$64K Sell
1,317
-188
-12% -$9.51K ﹤0.01% 2312
2016
Q2
$83K Buy
1,505
+1,129
+300% +$62.2K ﹤0.01% 2148
2016
Q1
$20K Sell
376
-8,956
-96% -$441K ﹤0.01% 2757
2015
Q4
$480K Buy
9,332
+7,759
+493% +$385K ﹤0.01% 1314
2015
Q3
$71K Sell
1,573
-113
-7% -$5.34K ﹤0.01% 2277
2015
Q2
$78K Sell
1,686
-1,572
-48% -$68.8K ﹤0.01% 2293
2015
Q1
$140K Sell
3,258
-606
-16% -$23.1K ﹤0.01% 1957
2014
Q4
$134K Buy
3,864
+214
+6% +$7.1K ﹤0.01% 1963
2014
Q3
$118K Sell
3,650
-1,995
-35% -$66.7K ﹤0.01% 2015
2014
Q2
$191K Sell
5,645
-3,100
-35% -$99.3K ﹤0.01% 1822
2014
Q1
$238K Buy
8,745
+219
+3% +$6.51K ﹤0.01% 1681
2013
Q4
$305K Sell
8,526
-639
-7% -$21.2K ﹤0.01% 1531
2013
Q3
$276K Sell
9,165
-690
-7% -$22.6K ﹤0.01% 1528
2013
Q2
$287K Buy
+9,855
New +$278K ﹤0.01% 1459

Other funds holding PBH

US Bancorp's PBH Position: Q2 2026 in Review

US Bancorp increased its Prestige Consumer Healthcare (PBH) stake by 2% in Q2 2026, buying an estimated $5.65K and bringing the position to 5,532 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1960.

US Bancorp first reported a position in PBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $541K in Q1 2022. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • US Bancorp held 5,532 shares of Prestige Consumer Healthcare worth $261K as of Q2 2026.
  • US Bancorp bought 110 Prestige Consumer Healthcare shares in Q2 2026, an estimated $5.65K.
  • Prestige Consumer Healthcare made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1960 holding.
  • US Bancorp first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's Prestige Consumer Healthcare position peaked at $541K in Q1 2022.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.